top of page
CO₂ reactivity as a biomarker of non-response to exposure-based therapy
Cognitive behavior therapy (CBT) is an effective treatment for anxiety and fear-related disorders. However, some patients fail to achieve complete remission or show a return of anxiety symptoms following treatment. The purpose of the study is to determine the extent to which one’s emotional reaction to a CO₂ inhalation task can help predict who might or might not respond to therapy. If CO₂ reactivity proves to be successful in predicting who will benefit from CBT versus who will not, clinicians can make better decisions about which patients should be treated with CBT.
Power in Numbers
Power in Numbers
National Institute of Mental Health
Sponsor
2
Locations
Currently recruiting participants
Status
bottom of page